ESC Premium Access

Twenty-year experience and outcomes in a national paediatric pulmonary hypertension service

Congress Session

About the speaker

Doctor Andrew Constantine

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
1 follower

4 more presentations in this session

Non-invasive risk prediction based on right ventricular function in patients with pulmonary arterial hypertension

Speaker: Mrs V. Qaderi (Melbourne, AU)


Inclusion of echocardiographic measure of right ventricular function in the non-invasive French pulmonary arterial hypertension risk stratification method

Speaker: Doctor C. Fauvel (Rouen, FR)


Safety, tolerability, and pharmacokinetics (PK) of treprostinil palmitil inhalation powder (TPIP): a phase 1, randomised, double-blind, single- and multiple-dose study

Speaker: Doctor F. Ismat (Bridgewater, US)


Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis

Speaker: Doctor J. Coghlan (London, GB)


Access the full session

Pulmonary arterial hypertension: risk stratification guides for new treatments and informed outcomes

Speakers: Doctor A. Constantine, Mrs V. Qaderi, Doctor C. Fauvel, Doctor F. Ismat, Doctor J. Coghlan

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Pregnancy and pulmonary hypertension.

27 August 2021

ESC Premium Access

Severe biventricular myocardial involvement in Systemic sclerosis.

27 August 2021

ESC Premium Access

Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database

27 August 2021

This platform is supported by

logo Novo Nordisk